| Alland, Leila (Affimed 201803– CMO before Tarveda Therapeutics + AstraZeneca + BMS + Novartis) |
Chief Medical Officer (CMO) |
Affimed (Group) |
Germany |
| Allcroft, Louise (Complement Genomics 200902 CEO) |
Chief Executive Officer (CEO) |
Complement Genomics Ltd. |
United Kingdom (GB) |
| Alldread, Richard (Lonza 201107 Head Technology Development + Strategic Projects at Lonza Development Services) |
Technical Manager |
Lonza (Group) |
Switzerland |
| Allemond, Pierre (Protein Metrics 201510– VP European Sales before Biovia/Dassault Systèmes + Accelrys + Chemspeed) |
Sales Manager / Marketing Manager |
Insightful Science (Group) |
Switzerland |
| Allen, Allison (Biovian 202209– Business Development Manager based in US before Cellectis + Alcami + Thermo Fisher) |
Business Development Manager / Strategy Manager |
Biovian Oy |
Finland |
| Allen, Chris (Broughton Laboratories 2011– Managing Director joind as Co-Founder 2006 before Sciantec Analytical) |
Managing Director |
Broughton Laboratories (GB) |
United Kingdom (GB) |
| Allen, Dave (GSK 201609 SVP KSG Pharma RnD) |
n. a. |
GSK (Group) |
United Kingdom (GB) |
| Allen, Debbie (Argen-X 201204 Senior Director Business Development) |
Business Development Manager / Strategy Manager |
Argenx (Argen-X) (Group) |
Netherlands |
| Allen, Keith (Syngenta Biotechnology Inc. 200604) |
n. a. |
Syngenta (Group) |
Switzerland |
| Allen, Mark (Elevian 202209 CEO) |
Chief Executive Officer (CEO) |
Elevian |
|
| Allen, Mark (Tripos 200508) |
n. a. |
Provid Pharmaceuticals (Group) |
United Kingdom (GB) |
| Allen, Peter (Celltech 1992–2004 CFO) |
Board member, non-executive |
UCB (Group) |
United Kingdom (GB) |
| Allen, Rich (PNC Financial Services 202009 at Solebury Trout) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Allenby, Gary (Aurelia Bioscience 202106 Co-Founder) |
Company Founder |
Charnwood Molecular (Group) |
United Kingdom (GB) |
| Allerberger, Franz (Austria (govt) 201005 Head Human Medicine Div of AGES) |
Professor |
Austria (govt) |
Austria |
| Alles, Mark (Celgene 201306 EVP + Global Head Hematology + Oncology) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Alles, Melanie (CSL Behring 201910– Senior Manager Global Pathogen Safety Suppart before Deutsche Bank) |
n. a. |
CSL (Group) |
Australia |
| Allgaier, Hermann (Merckle Biotec 200503 Managing Director) |
Managing Director |
Teva (Group) |
Germany |
| Allibert, Patrice (GenePOC 201607 CEO) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Canada |
| Allin, Steve (Charnwood Molecular 202207– Board Advisor + Investor before 1998–202207 CEO + Co-Founder) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Charnwood Molecular (Group) |
United Kingdom (GB) |
| Allinson, John (Icon plc 201011 VP Biomarker Lab Services) |
n. a. |
Icon plc (Group) |
Ireland, Republic of |
| Allmaier, Günter (Vienna University of Techology 201104 Professor) |
Professor |
Vienna University of Technology (TU Wien) |
Austria |
| Allmond, David (Novacyt 202110 CEO before Amryt Pharma + Amgen + Celgene + Aegerion Pharmaceuticals) |
Chief Executive Officer (CEO) |
Novacyt (Group) |
France |
| Allocca, Antonietta (Tecan 201611) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Allott, Stephen (Trinamo Ltd. 200708 Executive Chairman) |
Board member, executive |
Danaher (Group) |
United Kingdom (GB) |
| Allouche, Christian (Gleamer 202306 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Gleamer SAS |
France |
| Allouche, Florence (SparingVision –202010 President + Co-Founder LEFT 10/20) |
President/Director/Head Business Group/Unit/Division |
SparingVision SAS |
France |
| Alloueche, Ali (Affiris 201112– CBO before GSK Biologicals before Novartis Vaccines and Diagnostics) |
Chief Business Officer (CBO) |
Affiris AG |
Austria |
| Almagro, Juan Carlos (GlobalBio 202310 CEO + Founder) |
Chief Executive Officer (CEO) |
|
|
| Almasi, Barna (Imaging Service AG 200906 CTO) |
Chief Technology/Technical Officer (CTO) |
Imaging Service AG |
Germany |
| Almeida, José E. (Covidien 201112 CEO) |
Chief Executive Officer (CEO) |
Covidien (Group) |
Ireland, Republic of |
| Almond, Andrew (Imperagen 202208 CEO + Founder formerly Co-Founder of Conformetrix/C4X Discovery) |
Chief Executive Officer (CEO) |
Imperagen Ltd. |
United Kingdom (GB) |
| Almond-Thynne, Joshua (Sablebio 202308– Director + Co-Founder before BenevolentAI) |
Managing Director |
Sablebio Ltd. (Sable Bio) |
United Kingdom (GB) |
| Almstetter, Michael (Origenis 202012 Managing Director) |
Managing Director |
Origenis (Group) |
Germany |
| Alperstaedt, Melanie (ASC Ooncology 202102 Public Relations + Project Management) |
Public Relations Manager / Investor Relations Manager |
CellPhenomics (incl. ASC Oncology) (Group) |
Germany |
| Alpert, Amir (Immatics 202305 Director Technology Scouting + Development) |
n. a. |
Immatics (Group) |
Germany |
| Alramahy, Ehab (Biosynth 202309 SVP Head of Peptide Division) |
President/Director/Head Business Group/Unit/Division |
Biosynth (since 9/22) (Group) |
Switzerland |
| Alriksson, Maria (Abera Bioscience 202203 CEO) |
Chief Executive Officer (CEO) |
Abera Bioscience AB |
Sweden |
| Alsat, Valentin (Flash Therapeutics 202307 Financial Manager) |
Chief Financial Officer (CFO) |
Flash Therapeutics SAS |
France |
| Alsbo, Carsten (Exiqon 200904 Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Denmark |
| Alt, Eckhard (InGeneron 201710 Board Chairman) |
Board member |
InGeneron (Group) |
Germany |
| Altaba, Stéphane (LXRepair 202101– CEO before Genomic Vision + Nordic Pharma + Sanofi + Riken) |
Chief Executive Officer (CEO) |
LXRepair SAS |
France |
| Altenbach, H.-J. (Univ Wuppertal 201005 Professor) |
Professor |
University of Wuppertal |
Germany |
| Altendorf, Matthias (Endress+Hauser 202401– Supervisory Board Chair before CEO 2014–202312) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
| Altenhofen, Wolfram (Leucocare AG 201207 VP Business Development) |
Business Development Manager / Strategy Manager |
Leukocare (Group) |
Germany |
| Altevogt, Peter (DKFZ 200607 Professor) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Althoff, Gioia (Sophia Genetics 201904 SVP Genomics) |
President/Director/Head Business Group/Unit/Division |
Sophia Genetics (Group) |
Switzerland |
| Althusmann, Bernd (Niedersachsen (govt) 202207 Minister of Economic Affairs) |
Minister |
Niedersachsen (govt region) |
Germany |
| Altieri, Richard M. (Rick) (Oxford Immunotec 201311 CFO) |
Chief Financial Officer (CFO) |
Oxford Immunotec (Group) |
United Kingdom (GB) |
| Altink, Alexander (Kreatech 2000– CEO before van Ommeren & Ceteco) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Altmeier, Peter (Germany (govt) 201808 Minister of Economics) |
Minister |
Germany (govt) |
Germany |
| Altmeyer, Mark (Arvelle Therapeutics 201902– CEO before Axovant Sciences + BMS + Otsuka America Pharmaceutical) |
Chief Executive Officer (CEO) |
Angelini (Group) |
Switzerland |
| Altorfer, Michael (Swiss Biotech Association 201811 CEO before Polyphor + Roche + Ciba-Geigy + Sandoz + UBS Warburg) |
Chief Executive Officer (CEO) |
Swiss Biotech Association (SBA) |
Switzerland |
| Altshuler, David (Vertex 201510 EVP Global Research + CSO before Broad Institute 200510) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Vertex Pharmaceuticals (Group) |
United States (USA) |
| Álvarez Sánchez, Herminia (Nagi Bioscience 202309 Marketing + Business Development) |
Sales Manager / Marketing Manager |
Nagi Bioscience S.A. |
Switzerland |
| Álvarez, Leonardo (Protera 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Protera (Group) |
France |
| Álvarez-Martos, Isabel (Cellugy 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellugy (DK) |
Denmark |
| Alvers, Michael R. (Transinsight 200609 Managing Director + co-founder) |
Managing Director |
Transinsight GmbH |
Germany |
| Amabile, Giovanni (Enthera 202007 CEO) |
Chief Executive Officer (CEO) |
Enthera S.r.l. (Enthera Pharmaceuticals) |
Italy |
| Amado, Rafael G. (Allogene 201909– EVP RnD + CMO before Adaptimmune + GSK + Amgen + UCLA) |
Chief Medical Officer (CMO) |
Allogene Therapeutics Inc. (Nasdaq: ALLO) |
United States (USA) |
| Amadori, Giovanna (Chiesi Group 202011 Head of Global Strategy + Corporate Development) |
Business Development Manager / Strategy Manager |
Chiesi (Group) |
Italy |
| Amann, Anton (Medical Univ Innsbruck 201009 Professor) |
Professor |
Medical University Innsbruck (MUI) |
Austria |
| Amann, Manfred (Wacker) |
n. a. |
Wacker (Group) |
Germany |
| Amann, Rudolf |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Amar, Frédéric (Esperite 201801 CEO) |
Chief Executive Officer (CEO) |
Esperite (Group) |
Netherlands |
| Amariglio, Roy (OrbiMed 201605– Principal before Bayer HealthCare) |
Principal (venture capital) |
OrbiMed (Group) |
United States (USA) |
| Amat Riera, Jaume (Specific Pig 202203 CEO) |
Chief Executive Officer (CEO) |
Specific Pig S.L. (Specipig) |
Spain (España) |
| Amati, Luigi (Meta Group 201509 Investment Manager at Meta Ingenium) |
Investment Manager |
Meta Group (Group) |
|
| Amato, Antonino (Tony) (PinCell 202301– CEO) |
Chief Executive Officer (CEO) |
PinCell S.r.l. |
Italy |
| Amato, Marcos (Agdia 201508 Managing Director of Agdia-Biofords) |
Managing Director |
Agdia (Group) |
France |
| Amberger, Christoph (KWS 201207 Executive Board Member responsible for corn) |
Board member, executive |
KWS Saat (Group) |
Germany |
| Ambros, Reinhard (Versameb 201910c Board Chairman + Novartis Venture Fund) |
Board member, non-executive |
Versameb AG |
Switzerland |
| Ameres, Stefan (IMBA 2012– Group Lead + Quantro Therapeutics 202007 Co-Founder + Scientific Adivsor) |
Researcher (university / research institute) |
Austrian Academy of Sciences (ÖAW) |
Austria |
| Ameri, Jacqueline (Pancryos 202205 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Pancryos ApS |
Denmark |
| Amersdorfer, Peter (Lacerta Technologies GmbH 201401– CBO before Oridis Biomed 200705 Head BusDev) |
Chief Business Officer (CBO) |
OrthoSera (Group) |
Austria |
| Ameskamp, Nicole (Stada 201704 Managing Director of Norbitec GmbH) |
Managing Director |
Stada (Group) |
Germany |
| Ameye, Veronique (LumiraDx 202312 CEO) |
Chief Executive Officer (CEO) |
LumiraDx (Group) |
United Kingdom (GB) |
| Amidi, Saeed (Plug and Play 201706 CEO + Founder) |
Chief Executive Officer (CEO) |
Plug and Play (Group) |
United States (USA) |
| Amiel, Laurent (General Electric 201005 General Manager EMEA GE Healthcare Performance Solutions) |
General Manager (management) |
General Electric (Group) |
United Kingdom (GB) |
| Amiguet, Claude (Neode 2003– Director) |
President/Director/Head Business Group/Unit/Division |
Neode Science and Technology Park Neuchâtel |
Switzerland |
| Amijee, Hozefa (Ubiquigent 202211– Head of Business Development before Cellesce + RxCelerate + Total Scientific) |
Business Development Manager / Strategy Manager |
Ubiquigent Ltd. |
United Kingdom (GB) |
| Amin, Naseem (Arix Bioscience 202011 Executive Chairman) |
Board member, executive |
Arix Bioscience (Group) |
United Kingdom (GB) |
| Amitai, Mor (Compugen 200504 CEO) |
Chief Executive Officer (CEO) |
Compugen (Group) |
Israel |
| Amitay, Oved (Centogene 201811– CBO before Arrett Neuroscience + Alnylam + Genzyme) |
Chief Business Officer (CBO) |
Centogene (Group) |
Germany |
| Ammendola, Aldo (4SC 2010– Director Strategic Planning + Regulatory Affairs before Director Developm + QuaNova) |
Business Development Manager / Strategy Manager |
4SC (Group) |
Germany |
| Ammer, Richard (Medice Pharma 201704 Executive Board Member) |
Board member, executive |
Medice (Group) |
Germany |
| Ammermann, Detmar (Eppendorf 2006–2019 CFO joined in 1992 LEFT 2019) |
Chief Financial Officer (CFO) |
Eppendorf (Group) |
Germany |
| Ammon (formerly Alexandru), Anca (Ammon Communications 202103 before MorphoSys + Affimed + MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Amon, Peter (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
| Amoroso, Michael (Precision BioSciences 202110– CEO before Abeona Tx + Gilead/Kite + Eisai Inc + Celgene + Sanofi) |
Chief Executive Officer (CEO) |
Precision BioSciences (Group) |
United States (USA) |
| Amsallem, Gilles (Arbiom 201603 CEO before Biométhodes SA CEO) |
Chief Executive Officer (CEO) |
Arbiom (Group) |
United States (USA) |
| Amstutz, Patrick (Molecular Partners 201705– CEO before acting CEO before COO + Co-Founder) |
Chief Executive Officer (CEO) |
Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) |
Switzerland |
| Amzal, Billy (Quinten 202209 CEO of Quinten Health) |
Chief Executive Officer (CEO) |
Quinten (Group) |
France |
| An, Hyun Joo (Chungnam National Univ 201112 Professor at GRAST) |
Professor |
Chungnam National University |
Korea, Republic of |
| Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
| Anand, Mala (SAP 201610– President Intelligent Enterprise Solutions + Industries before Cisco 2007– 2016) |
President/Director/Head Business Group/Unit/Division |
SAP (Group) |
Germany |
| Anand, Ravi (Newron Pharmaceuticals 201103 CMO) |
Chief Medical Officer (CMO) |
Newron (Group) |
Italy |
| Ananth, Arun (Proscia 202301 Chief Commercial Officer) |
Chief Commercial Officer (CCO) |
Proscia Inc. |
United States (USA) |
| Ananth, Radhika (Accel 202101 Vice President) |
Investment Manager |
Accel (Group) |
India |
| Ancher-Jensen, Henrik (Agilent 201309– SVP + President of Agilent Order Fulfillment before Dako + Chr Hansen) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 ... 167 168 169 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
